Despite low circulating androgens in the CRPC patients, one potential mechanism that would allow tumor cell proliferation is by promoting the expression of the AR itself, which increases ligand-occupied receptor content (Feldman and Feldman, 2001). The gene discussed is AR; the disease is neoplasm.